[Evaluation of carbapenem prescribing practices at the Mohammed VI University Hospital in Marrakech]

Carbapenems are antibiotics of last resort reserved for severe infections with resistant germs, and the abuse of which makes us fear the emergence of resistance to carbapenem. The objective of this survey is to evaluate the relevance of carbapenem prescriptions in the Mohammed VI CHU in Marrakech. This is a prospective evaluation performed on a given day in January 2017. Included were all hospitalization services at the Arrazi Hospital and the Mother Child Hospital of the Marrakech CHU Mohamed VI, including resuscitation services. The investigation concerned all hospitalized patients present in the department on the day of the survey and for whom a carbapenem prescription was made. During the study period, 30 patients were prescribed carbapenem, 63% in intensive care units and 37% in surgery. This carbapenem mainly concerned adults [57%] followed by newborns [33%]. The reason for introducing carbapenem antibiotics was mainly sepsis [46, 5%]. Carbapenems were prescribed as second-line therapy after initial clinical treatment [73, 5%]. The imipenem was the most frequently prescribed carbapenem [83, 5%]. 80% of the infections justifying this prescription were nosocomial. A prescription after microbiological documentation was only found in 9 cases. This evaluation helped to better understand the typology of carbapenem prescriptions in our context

study of 166 plus 80 patients: CA breast treatment complications in CENAR quetta and IRNUM peshawar during 4 years from 1991 to 1994

A retrospective study for treatment complications of 166 patients of Carcinoma Breast was carried out from 1st January 1991 to 31st December 1994 in the Centre for Nuclear Medicine and Radiotherapy [CENAR], Quetta. During this period 2742 new cases of cancer were registered. Cancer of Breast constituted 623 [22.72%] of all. It was noted that this cancer was fourth most common cancer registered in this centre and was the most common cancer in female. 166 patients come for follow up regularly for 5 years after completion of treatment. In these female to male ratio was, 9.37:1. During this period of follow up, the treatment complications were noted in these patients to highlight the subject and to recommend the factors helpful to avoid the complication and management of these complications. During this period, the same study of 80 patients was carried out in IRNUM Peshawar for the same purpose